Maze Therapeutics, Inc. · NASDAQ:MAZE

Paradigm Biocapital Advisors LP reported a 6.10% stake in Maze Therapeutics, Inc. (Schedule 13G)

Event Mar 25, 2026 · Filed Apr 1, 2026

Paradigm Biocapital Advisors LP reported a 6.10% stake in Maze Therapeutics, Inc., 3,051,087 shares, as a passive investor on Mar 25, 2026. Filed Apr 1, 2026 (Schedule 13G).

Stake
6.10%
Shares
3,051,087
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP6.10%3,051,087
Paradigm BioCapital Advisors GP LLC6.10%3,051,087
Senai Asefaw, M.D.6.10%3,051,087
Paradigm BioCapital International Fund Ltd.5.40%2,688,520

Source

View original at SEC

Related